Company Directory / research

PrivateFor profitresearchMelbourne, Australia
OccuRx is a biopharmaceutical company that focuses on the development of innovative therapeutic strategies.
Size
1-10 people: larger than 0% of companies with a size listed
Age
12 years old.
Reach
Website ranked #14,268,985 in the world for traffic, about 55 visits a month.
BiopharmaBiotechnologyMedicalTherapeutics
Funding, as listed
$21M currency not stated
What the source datasets report. We have not watched these rounds ourselves.
Everything the source datasets list about OccuRx, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
About this record
Growth, as the source summarises it
OccuRx may be growing as it is listed among companies in the graft-versus-host disease market, which is expected to see an upsurge in growth during the forecast period. The company is also mentioned in the context of the Chronic Kidney Disease clinical trial pipeline, indicating active involvement in developing treatments in this area. Furthermore, OccuRx appears alongside other companies in a discussion about the growth potential of the Chronic Kidney Disease pipeline domain, suggesting that it is part of a sector that is anticipating growth.
Summaries written by the source dataset, not by us, and not checked.
research in Australia.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 128,574 companies in Australia and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.